Dana-Farber Cancer Institute

308 articles about Dana-Farber Cancer Institute

• Cytomegalovirus Might Speed Brain-Cancer Growth, Ohio State University Comprehensive Cancer Center and Dana-Farber Cancer Institute Study

  6/3/2013

• Dana-Farber Cancer Institute Scientists Find Mutation Driving Pediatric Brain Tumors

  5/1/2013

• Some Incurable BRCA Patients Respond to New 2-Drug Combo, Dana-Farber Cancer Institute Study

  4/8/2013

• Screening Blood Samples for Cancer-Driving Mutations More Comprehensive Than Analyzing Traditional Tumor Biopsy, Dana-Farber Cancer Institute and Harvard Medical School Study

  4/8/2013

• BrainStorm Cell Therapeutics Inc. Partners With Dana-Farber Cancer Institute for NurOwn™ Production in Phase II ALS Clinical Trial

  4/8/2013

• The Mikey Czech Foundation Contributes $500,000 to DIPG Research at Dana-Farber Cancer Institute - Harvard Medical School

  4/2/2013

• Molecular "Signature" for Rapidly Increasing Form of Esophageal Cancer Discovered, Dana-Farber Cancer Institute Study

  3/25/2013

• Rheumatoid Arthritis Prevented in Mice: Infusions of Regulatory T Cells Turn Off Autoimmune Attack on Joints, Dana-Farber Cancer Institute Study

  2/11/2013

• New Method Identifies Genes That Can Predict Prognoses of Cancer Patients, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute and IRCM Study

  1/28/2013

• Mutations Found in "Junk" DNA May be Driving Skin Cancers, Dana-Farber Cancer Institute Study

  1/25/2013

• Some Men Complaint of Shortened Penis Following Prostate Cancer Treatment, Dana-Farber Cancer Institute and Brigham and Women's Hospital Study

  1/3/2013

• Blood Levels of Immune Protein Predict Risk in Hodgkin Disease, Dana-Farber Cancer Institute Study

  12/11/2012

• Second Stem Cell Expert From Harvard University's Dana-Farber Cancer Institute Joins Cryo-Cell International

  11/13/2012

• High Carbohydrate Diet May Up Colon Cancer Risk, Dana-Farber Cancer Institute Study

  11/8/2012

• GNS Healthcare, Dana-Farber Cancer Institute and Mount Sinai School of Medicine Collaborate to Build Computer Model of Multiple Myeloma

  11/8/2012

• Are Cancer Patients' Hopes for Chemo Too High? Dana-Farber Cancer Institute Study

  10/25/2012

• Clinical Trials Going Active for Cellceutix Anti-Cancer Drug Kevetrin

  10/8/2012

• New Study Demonstrating Progenra, Inc.'s Novel Anti-Tumor Compound Overcome VELCADE® (bortezomib) Resistant Multiple Myeloma Cells

  9/17/2012

• Cancer Study Points to Tighter Pairing of Drugs and Patients, Dana-Farber Cancer Institute Study

  9/10/2012

• Dana-Farber Cancer Institute's Ursula A. Matulonis, MD Article on EntreMed, Inc.'s ENMD-2076 Published in the European Journal of Cancer

  9/6/2012